Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Multiple Myeloma, Smoldering”

115 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 115 results

Not applicableLooking for participantsNCT06745687
What this trial is testing

BCMA/CD3 BsAb in the Treatment of High-risk Smoldering Multiple Myeloma

Who this might be right for
High Risk Smoldering Multiple Myeloma
Institute of Hematology & Blood Diseases Hospital, China 20
Not applicableLooking for participantsNCT06237803
What this trial is testing

European Myeloma Network (EMN) Sample Project

Who this might be right for
Multiple MyelomaSmoldering Multiple MyelomaPlasma Cell Leukemia+2 more
European Myeloma Network B.V. 6,000
Not applicableStudy completedNCT01955395
What this trial is testing

Genomic and Psychosocial Effects of the 3RP on Patients With MGUS and Smoldering Multiple Myeloma

Who this might be right for
Monoclonal Gammopathy of Undetermined SignificanceSmoldering Multiple Myeloma
Dana-Farber Cancer Institute 93
Testing effectiveness (Phase 2)Looking for participantsNCT05469893
What this trial is testing

Immuno-PRISM (PRecision Intervention Smoldering Myeloma)

Who this might be right for
High-risk Smoldering Multiple MyelomaSmoldering Multiple MyelomaMultiple Myeloma
Irene Ghobrial, MD 52
Testing effectiveness (Phase 2)Ended earlyNCT02943473
What this trial is testing

Study on the Effect of Ibrutinib on High Risk Smoldering Multiple Myeloma Patients

Who this might be right for
High Risk Smoldering Multiple Myeloma
Icahn School of Medicine at Mount Sinai 9
Testing effectiveness (Phase 2)Study completedNCT01094548
What this trial is testing

Study of Tecemotide (L-BLP25) in Subjects With Slowly Progressive Multiple Myeloma With no Symptoms and Who Have Had no Chemotherapy

Who this might be right for
Multiple Myeloma
Merck KGaA, Darmstadt, Germany 34
Testing effectiveness (Phase 2)Active Not RecruitingNCT05955508
What this trial is testing

A Proof-of-Concept Trial to Study the Safety and Activity of Linvoseltamab in Adult Participants With Smoldering Multiple Myeloma at High Risk of Developing Multiple Myeloma

Who this might be right for
Smoldering Multiple Myeloma (SMM)
Regeneron Pharmaceuticals 40
Not applicableLooking for participantsNCT06212323
What this trial is testing

Smoldering Myeloma High-Risk Patient Observation and Longitudinal Insight Trial

Who this might be right for
Smoldering Multiple Myeloma
University of Utah 100
Large-scale testing (Phase 3)Study completedNCT03301220
What this trial is testing

Subcutaneous Daratumumab Versus Active Monitoring in Participants With High-Risk Smoldering Multiple Myeloma

Who this might be right for
Smoldering Multiple Myeloma
Janssen Research & Development, LLC 390
Not applicableLooking for participantsNCT06055894
What this trial is testing

A Plant-Based Diet and Dietary Supplements in People With Smoldering Multiple Myeloma (SMM) or Monoclonal Gammopathy of Undetermined Significance (MGUS)

Who this might be right for
Multiple Myeloma, SmolderingMultiple MyelomaMonoclonal Gammopathy of Undetermined Significance
Memorial Sloan Kettering Cancer Center 200
Early research (Phase 1)UnknownNCT02240537
What this trial is testing

Phase I Study of an Oncofetal Antigen Multi-Peptide Immunotherapy in Subjects With Hematologic Cancer

Who this might be right for
Acute Myelogenous Leukemia (AML)Multiple Myeloma (MM)Myelodysplastic Syndrome (MDS)+1 more
Benovus Bio, Inc. 4
Testing effectiveness (Phase 2)Study completedNCT02903381
What this trial is testing

A Phase II Trial If Nivolumab, Lenalidomide and Dexamethasone in High Risk Smoldering Myeloma

Who this might be right for
Smoldering Multiple Myeloma
Dana-Farber Cancer Institute 8
Testing effectiveness (Phase 2)Ended earlyNCT05288062
What this trial is testing

Immunomodulatory Drugs (Lenalidomide With or Without Pomalidomide) in Combination With a Corticosteroid Drug (Dexamethasone) for the Treatment of Multiple Myeloma

Who this might be right for
Plasma Cell MyelomaRecurrent Plasma Cell MyelomaRefractory Plasma Cell Myeloma+1 more
Mayo Clinic 17
Testing effectiveness (Phase 2)Looking for participantsNCT06140524
What this trial is testing

A Proof-of-Concept Study to Learn Whether Linvoseltamab Can Eliminate Abnormal Plasma Cells That May Lead to Multiple Myeloma in Adult Patients With High-Risk Monoclonal Gammopathy of Undetermined Significance or Non-High-Risk Smoldering Multiple Myeloma

Who this might be right for
Monoclonal Gammopathy of Undetermined Significance (MGUS)Smoldering Multiple Myeloma (SMM)
Regeneron Pharmaceuticals 116
Not applicableUnknownNCT05047107
What this trial is testing

Biology and Genetics of Smouldering Myeloma

Who this might be right for
Smouldering MyelomaMGUSMultiple Myeloma
University College, London 500
Testing effectiveness (Phase 2)Study completedNCT01441973
What this trial is testing

Biomarker Study of Elotuzumab in High Risk Smoldering Myeloma

Who this might be right for
Smoldering Multiple Myeloma
Bristol-Myers Squibb 41
Testing effectiveness (Phase 2)Ended earlyNCT01302366
What this trial is testing

A Trial of TBL12 Sea Cucumber Extract in Patients With Untreated Asymptomatic Myeloma

Who this might be right for
Myeloma
NYU Langone Health 20
Not applicableWithdrawnNCT02298816
What this trial is testing

B-Cell Hematologic Malignancy Vaccination Registry

Who this might be right for
Monoclonal Gammopathy of Undetermined SignificanceMultiple MyelomaWaldenstrom Macroglobulinemia+4 more
Wake Forest University Health Sciences
Very early researchStudy completedNCT03631043
What this trial is testing

Personalized Vaccine in Treating Patients With Smoldering Multiple Myeloma

Who this might be right for
Smoldering Plasma Cell Myeloma
M.D. Anderson Cancer Center 30
Testing effectiveness (Phase 2)WithdrawnNCT00503763
What this trial is testing

Efficacy and Safety of Statin on the Course of Progressive Smoldering Multiple Myeloma

Who this might be right for
Smoldering Multiple Myeloma
Meir Medical Center
Next Page